No Data
No Data
Cspc innovation pharmaceutical (300765.SZ): The holding subsidiary's authorized drug has obtained the usa FDA fast track designation.
格隆汇Dec 4th | CSPC Innovation Pharmaceutical (300765.SZ) announced that its controlling subsidiary CSPC Pharma Group's Jushi Biopharmaceutical Co., Ltd. authorized Corbus Pharmaceuticals, Inc. (hereinafter referred to as "Corbus") to develop CRB-701 (SYS6002), which has been granted fast track designation by the U.S. Food and Drug Administration for the treatment of recurrent or refractory metastatic cervical cancer. The product is a next-generation antibody-drug conjugate (ADC) targeting Nectin-4, containing a site-specific cleavable linker, allowing for
Market bullish stimulus boosts Hong Kong pharmaceutical stocks, with Genshuo Niaoyao rising over 14%.
① What bullish impacts does the medical insurance centralized procurement have on pharmaceutical companies? ② How do institutions view the subsequent development of pharmaceutical stocks?
China Securities Co.,Ltd.: In the 2024 version of the medical insurance catalog, the number of innovative drugs added has reached a new high, balancing 'ensuring basic coverage' and 'supporting genuine innovation'.
Overall situation of the 2024 medical insurance catalog: the results are stable, meeting expectations, with a record high in the number of new innovative drugs, reflecting a balanced consideration of fund safety, public medical needs, and support for innovation.
On November 29, cspc pharma (01093) spent 29.5338 million HKD to repurchase 5.8 million shares.
cspc pharma (01093) announced that on November 29, 2024, it spent 29.5338 million Hong Kong dollars to repurchase 58...
Zhixun Hong Kong stocks repurchase statistics | November 29th
Hong Kong stock buyback statistics | November 29
cspc pharma (01093.HK) spent 29.528 million Hong Kong dollars on November 28th to repurchase 5.8 million shares.
Gelonghui November 28 │ cspc pharma (01093.HK) announced that on November 28, 2024, it invested 29.528 million Hong Kong dollars to repurchase 5.8 million shares, at a repurchase price of 5.05-5.16 Hong Kong dollars per share.
Willis88 : Junk stocks